Clinical Data Collection and Analysis

The audit of clinical outcomes is one of the cornerstones of the foundation for good medical practice, and the BABS annually collects this type of data from its member doctors.  Comparing this with national data on specific quality and performance indicators allows the BABS to establish average baseline trends in the specific sector of body sculpting.

Each year a log is compiled of the number of procedures performed, the areas of the body that have been treated and other specifics of patient characteristics.  These are then used to assess performance ratios of successful outcomes and patient satisfaction.

The process of data collection and analysis not only establishes guidelines on the rate of risk, but also helps frame objectives for efforts of continuous improvement.

All data collected by the BABS is anonymised, and strictly adheres to all laws and best practices concerning the governance of data protection.


Data collection objectives
1.  Trends in the frequency of body sculpting and cosmetic surgery procedures, including the number of the procedures performed, types of procedures, and clinical outcomes (revision rate, satisfaction levels, and side effects).

2. Monitoring of adverse effects and their management.  Specific adverse effects include infection, poor scarring, skin necrosis, fat embolisms, lidocaine toxicity, serum formation, DVT/PE, bleeding, and death.  Individual member performance in dealing with the adverse effects is captured through Significant Event and Never Event analysis reports . 

3. Complaints and feedback information gathering from patients. 


Quality assurance of the data


All information supplied by a doctor to the BABS is verified by his or her appraiser (independently appointed by a Designated Body) during a compulsory, annual doctor's appraisal. Furthermore, all supplied information is checked by CQC inspectors during their site visits to clinician practices.  If doctor's figures deviate significantly from peer averages his or her performance will be examined by the BABS Clinical Governance lead in collaboration with the doctor's appraiser. Doctor will be offered training and support as necessary. Voluntary practice restrictions might be recommended for a period of review. The Clinical Governance committee of BABS prepares compilations of the data for assessing national trends, and makes this is available to the public